Notably, after in-vitro expansion in the presence of exogenous TGFβ (6 days), a considerable CXCL13 production was found only in cells from the tumor, mainly characterized by a PD1+CD28− TRM phenotype, and not in NT tissue (Fig. S9A-C). This evidence concerns the gene CD28 and neoplasm.